IMAGE: MouseAge.Org provides tools for cross-species analysis, and provide correlations between health and appearance. Tuesday, 29th of August, 2017, Baltimore, MD - Insilico Medicine, Inc, a Baltimore-based next-generation artificial intelligence company, today announced its participation in the MouseAge.org The scientists from Insilico Medicine will collaborate with scientists from Harvard, Oxford, Youth Laboratories, the Biogerontology Research Foundation, and other institutions to enable scientists worldwide to derive more information from rodent studies, develop novel biomarkers of aging and various diseases in mice, develop tools for cross-species analysis, and provide correlations between health and appearance. The project campaign has been launched today at research crowdfunding platform Lifespan.io. The project was conceived by Vadim Gladyshev, Professor of Medicine at Brigham and Women's Hospital, Harvard Medical School, and Alex Zhavoronkov, CEO of Insilico Medicine.